New hope for advanced colon cancer patients in drug combo trial

NCT ID NCT04660812

Summary

This study tested new combinations of drugs, including an experimental one called etrumadenant, for people with advanced colorectal cancer that has spread. It involved 227 participants and aimed to see if these combinations could control the cancer better than standard treatments while being safe. The trial compared different drug groups, including some without traditional chemotherapy, to measure how long the cancer stayed under control and how patients responded.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Aberdeen Royal Infirmary

    Aberdeen, Scotland, AB25 2ZN, United Kingdom

  • American Oncology Partners of Maryland PA

    Bethesda, Maryland, 20817, United States

  • Arizona Clinical Research Center Inc

    Tucson, Arizona, 85715, United States

  • Asan Medical Center | University of Ulsan College of Medicine

    Seoul, 5538, South Korea

  • Azienda Ospedaliera Niguarda Ca' Granda

    Milan, 20141, Italy

  • Azienda Ospedaliero Universitaria Careggi-S.O.D. Patologia Medica

    Florence, 50134, Italy

  • Belfast City Hospital

    Belfast, Northern Ireland, BT9 7AB, United Kingdom

  • CHU la Miletrie

    Poitiers, 86000, France

  • Centre Georges Francois Leclerc

    Dijon, 21000, France

  • Chonnam National University Hwasun Hospital

    Hwasun, 58128, South Korea

  • City of Hope Comprehensive Cancer Center

    Duarte, California, 91010, United States

  • Clinica Universidad Navarra-Sede Madrid

    Pamplona, 31008, Spain

  • Complejo Hospitalario de Orense

    Ourense, 32005, Spain

  • Comprehensive Cancer Centers Of Nevada

    Las Vegas, Nevada, 89169, United States

  • Corporacio Sanitaria Parc Tauli

    Sabadell, 8208, Spain

  • Groupe Hospitalier Pitie-Salpetriere-Centre De Recherche et de Medecine de l'Obesite

    Paris, 75651, France

  • Hopital Hotel Dieu

    Nantes, 44093, France

  • Hopital Saint Antoine

    Paris, 75012, France

  • Hospital General Universitario Gregorio Maranon

    Madrid, 28046, Spain

  • Hospital Universitario La Paz

    Madrid, 28007, Spain

  • IRCCS - Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis

    Castellana Grotte, 70013, Italy

  • Institut Bergonie - Centre Regional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest

    Bordeaux, 33076, France

  • Instituto Europeo di Oncologia

    Milan, 20162, Italy

  • Istituto Clinico Humanitas IRCCS

    Rozzano, 20089, Italy

  • Korea University Anam Hospital

    Seoul, 8241, South Korea

  • Kyungpook National University Chilgok Hospital

    Seoul, South Korea

  • NYU Langone Medical Center - NYU Medical Oncology Associates

    New York, New York, 10016, United States

  • New York-Presbyterian Hospital-Columbia University Medical Center

    New York, New York, 10032, United States

  • Ochsner Medical Center (OMC)

    New Orleans, Louisiana, 70121, United States

  • Prisma Health-Upstate

    Greenville, South Carolina, 29605, United States

  • Samsung Medical Center

    Seoul, 6351, South Korea

  • Sarah Cannon Research Institute

    Nashville, Tennessee, 37232, United States

  • Seoul National University Bundang Hospital

    Seoul, 13620, South Korea

  • Seoul National University Hospital (SNUH)

    Seoul, 3080, South Korea

  • Severance Hospital | Yonsei University Health System

    Seoul, 3722, South Korea

  • Sibley Memorial Hospital

    Washington D.C., District of Columbia, 20016-2633, United States

  • The University of Texas MD Anderson Cancer Center

    Houston, Texas, 77030, United States

  • UCLA Hematology Oncology

    Santa Monica, California, 90404, United States

  • Universita di Siena - Azienda Ospedaliera Universitaria Senese-Policlincio Santa Maria Alle Scotte

    Siena, 53100, Italy

  • University of Wisconsin School of Medicine

    Madison, Wisconsin, 53792, United States

  • Vanderbilt-Ingram Cancer Center

    Nashville, Tennessee, 37203, United States

  • Washington University School of Medicine

    St Louis, Missouri, 63110, United States

  • Winship Cancer Institute at Emory University

    Atlanta, Georgia, 30322, United States

  • Yale Cancer Center

    New Haven, Connecticut, 06510, United States

Conditions

Explore the condition pages connected to this study.